Dosage-dependence of Graded Exercise Therapy in Patients With Patellofemoral Pain Syndrome.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01290705|
Recruitment Status : Completed
First Posted : February 7, 2011
Last Update Posted : February 18, 2016
|Condition or disease||Intervention/treatment||Phase|
|Patellofemoral Pain Syndrome||Behavioral: High exercise therapy Behavioral: Low exercise therapy||Not Applicable|
Exercise therapy is widely used in the conservative treatment of patellofemoral pain syndrome (PFPS), but there is still no consensus on recommending any specific rehabilitation program.
This study evaluates two different therapeutic exercise regimens in patients with PFPS and their effect on pain at rest and function.
Supervised exercise therapy will be applied in both groups three times a week over a 3-month period with individually tailored and graded exercise programs, differing between groups in terms of number of exercises, number of repetitions and sets, and time spent on performing aerobic exercises.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||40 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Investigator)|
|Official Title:||Dosage-dependence of Graded Exercise Therapy in Patients With Patellofemoral Pain Syndrome. A Randomized Controlled Clinical Trial.|
|Study Start Date :||November 2007|
|Actual Primary Completion Date :||December 2010|
|Actual Study Completion Date :||December 2010|
Experimental: high exercise
High dose, high repetition exercise therapy, 3 times weekly in 12 weeks
Behavioral: High exercise therapy
Experimental: low exercise
low dose, low repetition exercise therapy, 3 times weekly in 12 weeks
Behavioral: Low exercise therapy
- Pain measured by a Visual analogue scale (VAS). [ Time Frame: Pre-test, post-test (after completed intervention at 3 months) and one year follow-up. ]This scale was illustrated with a 100 mm horizontal line with descriptors "no pain" at the 0 mm mark and "worst pain imaginable" anchoring the 100 mm. Participants were required to place a vertical mark on the horizontal line, representing their average level of pain experienced during the last 24 hours. This was done at rest and provided an illustration of the perceived pain severity, rated in millimetres.
- Function measured by a Step-down test and by a modified Functional Index Questionnaire (FIQ). [ Time Frame: Pre-test, post-test (at 3 months after completed intervention) and at one year follow-up. ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01290705
|Study Director:||Jan Harry Størksen||Norwegian University of Science and Technology|